Search
for
Sort by
Research 331–360 of 1000+
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Clinical and Dermoscopic Evaluation of the Safety and Efficacy of Oral baricitinib (JAK Inhibitor) in Treatment of Localized Vitiligo Either Alone or with Topical Tacrolimus
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Treatment of alopecia areata with JAK inhibitors
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- TREMendous Macrophages Inhibit Hair Growth
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- The Role of Janus Kinase Inhibitors in Dermatology
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Alopecia Areata: JAK Inhibitors—PRP and Exosomes
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- JAK inhibitors in dermatology: The promise of a new drug class
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata